(EMAILWIRE.COM, October 28, 2017 ) Market Research Hub's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, h2, 2017" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Market Research Hub Clinical Trial Reports are generated using Market Research Hubs proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
- Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5
Market Research Hub Clinical Trials Report Coverage 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 16 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20 Clinical Trials in E7 Countries by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Clinical Trials by End Point Status 25 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28
Top Companies Participating in High-Grade Glioma Therapeutics Clinical Trials 29 Prominent Drugs 30 Latest Clinical Trials News on High-Grade Glioma 31 Aug 22, 2017: Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas 31 Clinical Trial Profile Snapshots 32 Appendix 182 Abbreviations 182 Definitions 182 Research Methodology 183 Secondary Research 183 About Market Research Hub 184 Contact Us 184 Disclaimer 184 Source 185
List of Tables High-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2017* 7 High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9 High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10 High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11 High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12 High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2017* 13 High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14 High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15 Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2017* 16 High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18 Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2017* 19 High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20 High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21 High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2017* 22 High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24 High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25 High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26 High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27 High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28 High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29 High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
List of Figures High-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8 High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10 High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11 High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12 High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13 High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14 High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2017* 16 High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17 High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18 Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2017* 19 Continue….
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
